Urban and Rural Differences in Cancer Treatment Disruption Among Patients With COVID‐19: An Analysis of the US ASCO COVID‐19 in Oncology Registry
ABSTRACT Introduction Cancer patients in rural areas experience greater barriers to treatment access compared with patients in urban areas. There is limited research on how the COVID‐19 pandemic affected cancer treatment delivery for rural patients who were also diagnosed with COVID‐19. This study h...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.70512 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832589809821941760 |
|---|---|
| author | Yu Chen Lin Kea Turner Oliver T. Nguyen Emma Hume Marlene Camacho‐Rivera Jessica Y. Islam |
| author_facet | Yu Chen Lin Kea Turner Oliver T. Nguyen Emma Hume Marlene Camacho‐Rivera Jessica Y. Islam |
| author_sort | Yu Chen Lin |
| collection | DOAJ |
| description | ABSTRACT Introduction Cancer patients in rural areas experience greater barriers to treatment access compared with patients in urban areas. There is limited research on how the COVID‐19 pandemic affected cancer treatment delivery for rural patients who were also diagnosed with COVID‐19. This study has two objectives: to assess (1) the urban–rural differences in cancer care and (2) the predictors of cancer treatment delay or discontinuation (TDD) among patients diagnosed with COVID‐19. Methods We used data from the American Society of Clinical Oncology Survey on COVID‐19 in Oncology Registry (March 2020–September 2022), which included cancer patients with test‐confirmed SARS‐CoV‐2 infection (N = 3797). Data included patient sociodemographic characteristics, COVID‐19 diagnosis information, cancer clinical characteristics, and changes to cancer treatment. Cancer TDD was defined as any scheduled treatment by more than 2 weeks. Rurality was examined through both patient residence and oncology practice. We computed adjusted prevalence ratios (aPRs) using multivariable Poisson regressions to assess predictors of cancer TDD in urban and rural areas. Results During the study period, 44.1% of patients with COVID‐19 experienced either cancer treatment delay or discontinuation and 5.7% experienced cancer treatment discontinuation. Controlling for other factors, receiving care in a rural oncology practice was associated with cancer TDD (aPR: 1.25, 95% CI: 1.01–1.55). Differences in cancer TDD were not found across rurality of patient residence. Among rural patients (N = 582), Hispanic/Latinx cancer patients had greater prevalence of cancer TDD (aPR: 1.55, 95% CI: 1.04–2.33) compared with non‐Hispanic White cancer patients. Conclusion Our findings can be used to inform programs and policies to minimize the impact of future public health emergencies on cancer care delivery in rural areas. Additional research is needed to explore potential differences in cancer care delivery across urban and rural oncology practices and patients. |
| format | Article |
| id | doaj-art-f73dd5f70a5b4959995bcb5c1840dfcb |
| institution | Kabale University |
| issn | 2045-7634 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Cancer Medicine |
| spelling | doaj-art-f73dd5f70a5b4959995bcb5c1840dfcb2025-01-24T08:46:07ZengWileyCancer Medicine2045-76342025-01-01142n/an/a10.1002/cam4.70512Urban and Rural Differences in Cancer Treatment Disruption Among Patients With COVID‐19: An Analysis of the US ASCO COVID‐19 in Oncology RegistryYu Chen Lin0Kea Turner1Oliver T. Nguyen2Emma Hume3Marlene Camacho‐Rivera4Jessica Y. Islam5Department of Health Outcomes and Behavior Moffitt Cancer Center Tampa Florida USADepartment of Health Outcomes and Behavior Moffitt Cancer Center Tampa Florida USADepartment of Health Outcomes and Behavior Moffitt Cancer Center Tampa Florida USADepartment of Health Outcomes and Behavior Moffitt Cancer Center Tampa Florida USADepartment of Community Health Sciences SUNY Downstate Health Sciences University Brooklyn New York USADepartment of Cancer Epidemiology Moffitt Cancer Center Tampa Florida USAABSTRACT Introduction Cancer patients in rural areas experience greater barriers to treatment access compared with patients in urban areas. There is limited research on how the COVID‐19 pandemic affected cancer treatment delivery for rural patients who were also diagnosed with COVID‐19. This study has two objectives: to assess (1) the urban–rural differences in cancer care and (2) the predictors of cancer treatment delay or discontinuation (TDD) among patients diagnosed with COVID‐19. Methods We used data from the American Society of Clinical Oncology Survey on COVID‐19 in Oncology Registry (March 2020–September 2022), which included cancer patients with test‐confirmed SARS‐CoV‐2 infection (N = 3797). Data included patient sociodemographic characteristics, COVID‐19 diagnosis information, cancer clinical characteristics, and changes to cancer treatment. Cancer TDD was defined as any scheduled treatment by more than 2 weeks. Rurality was examined through both patient residence and oncology practice. We computed adjusted prevalence ratios (aPRs) using multivariable Poisson regressions to assess predictors of cancer TDD in urban and rural areas. Results During the study period, 44.1% of patients with COVID‐19 experienced either cancer treatment delay or discontinuation and 5.7% experienced cancer treatment discontinuation. Controlling for other factors, receiving care in a rural oncology practice was associated with cancer TDD (aPR: 1.25, 95% CI: 1.01–1.55). Differences in cancer TDD were not found across rurality of patient residence. Among rural patients (N = 582), Hispanic/Latinx cancer patients had greater prevalence of cancer TDD (aPR: 1.55, 95% CI: 1.04–2.33) compared with non‐Hispanic White cancer patients. Conclusion Our findings can be used to inform programs and policies to minimize the impact of future public health emergencies on cancer care delivery in rural areas. Additional research is needed to explore potential differences in cancer care delivery across urban and rural oncology practices and patients.https://doi.org/10.1002/cam4.70512cancer care deliveryCOVID‐19 pandemichealth disparitieshealth equityrural health |
| spellingShingle | Yu Chen Lin Kea Turner Oliver T. Nguyen Emma Hume Marlene Camacho‐Rivera Jessica Y. Islam Urban and Rural Differences in Cancer Treatment Disruption Among Patients With COVID‐19: An Analysis of the US ASCO COVID‐19 in Oncology Registry Cancer Medicine cancer care delivery COVID‐19 pandemic health disparities health equity rural health |
| title | Urban and Rural Differences in Cancer Treatment Disruption Among Patients With COVID‐19: An Analysis of the US ASCO COVID‐19 in Oncology Registry |
| title_full | Urban and Rural Differences in Cancer Treatment Disruption Among Patients With COVID‐19: An Analysis of the US ASCO COVID‐19 in Oncology Registry |
| title_fullStr | Urban and Rural Differences in Cancer Treatment Disruption Among Patients With COVID‐19: An Analysis of the US ASCO COVID‐19 in Oncology Registry |
| title_full_unstemmed | Urban and Rural Differences in Cancer Treatment Disruption Among Patients With COVID‐19: An Analysis of the US ASCO COVID‐19 in Oncology Registry |
| title_short | Urban and Rural Differences in Cancer Treatment Disruption Among Patients With COVID‐19: An Analysis of the US ASCO COVID‐19 in Oncology Registry |
| title_sort | urban and rural differences in cancer treatment disruption among patients with covid 19 an analysis of the us asco covid 19 in oncology registry |
| topic | cancer care delivery COVID‐19 pandemic health disparities health equity rural health |
| url | https://doi.org/10.1002/cam4.70512 |
| work_keys_str_mv | AT yuchenlin urbanandruraldifferencesincancertreatmentdisruptionamongpatientswithcovid19ananalysisoftheusascocovid19inoncologyregistry AT keaturner urbanandruraldifferencesincancertreatmentdisruptionamongpatientswithcovid19ananalysisoftheusascocovid19inoncologyregistry AT olivertnguyen urbanandruraldifferencesincancertreatmentdisruptionamongpatientswithcovid19ananalysisoftheusascocovid19inoncologyregistry AT emmahume urbanandruraldifferencesincancertreatmentdisruptionamongpatientswithcovid19ananalysisoftheusascocovid19inoncologyregistry AT marlenecamachorivera urbanandruraldifferencesincancertreatmentdisruptionamongpatientswithcovid19ananalysisoftheusascocovid19inoncologyregistry AT jessicayislam urbanandruraldifferencesincancertreatmentdisruptionamongpatientswithcovid19ananalysisoftheusascocovid19inoncologyregistry |